Literature DB >> 7135793

Fetal rat development as influenced by maternal lead exposure.

C D Miller, W B Buck, F B Hembrough, W L Cunningham.   

Abstract

The teratogenic and neurologic effects of lead acetate on fetal rat development were investigated. Thirty-six female hooded rats were assigned to 4 treatment groups (0, 50, 75, and 100 mg/kg) and given daily oral doses of lead acetate. Animals were treated for 3 weeks prior to breeding and continuing throughout gestation. Rats were euthanized at day 20 of gestation. Blood sampling indicated that maternal blood lead concentrations in treated dams were maintained during gestation. Lead exposed groups had significant (at least p less than .01) maternal kidney and liver as well as fetal kidney lead content. Conceptus weight was significantly reduced in treatment groups. It was concluded that although significant amounts of lead crossed the placenta, as exemplified by fetal kidney values, no teratogenic response or reduction in fetal brain DNA content was produced in the rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7135793

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  4 in total

Review 1.  Hormonal regulation and implication of cell signaling in calcium transfer by placenta.

Authors:  J Lafond; I Goyer-O'Reilly; M Laramée; L Simoneau
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Congenital lead encephalopathy in monkeys.

Authors:  B Lögdberg; A Brun; M Berlin; A Schütz
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 3.  Calcium-binding proteins: distribution and implication in mammalian placenta.

Authors:  Louiza Belkacemi; Lucie Simoneau; Julie Lafond
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

4.  Lead and cadmium in human placentas and maternal and neonatal blood (in a heavily polluted area) measured by graphite furnace atomic absorption spectrometry.

Authors:  I Baranowska
Journal:  Occup Environ Med       Date:  1995-04       Impact factor: 4.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.